DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. | MicrobiomeTrials
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-04
Enrollment target: 120 participants
Locations
Exalt Clinical Research, Chula Vista, California, United States
Teradan Clinical Trials LLC, Brandon, Florida, United States
CNS Healthcare - Jacksonville, Jacksonville, Florida, United States
CNS Healthcare Orlando, Orlando, Florida, United States
Palm Beach Research Center, West Palm Beach, Florida, United States
Conquest Research/Neurotrials, Winter Park, Florida, United States
Tandem Clinical Research, Marrero, Louisiana, United States
Velocity Clinical Research, Rockville, Rockville, Maryland, United States
CTI Clinical Research Center, Cincinnati, Ohio, United States
Intrepid Research, Cincinnati, Ohio, United States
Velocity Clinical Research, Anderson, Anderson, South Carolina, United States
CNS Healthcare - Memphis, Memphis, Tennessee, United States
FutureSearch Trials of Dallas, Dallas, Texas, United States
Sleep Therapy & Research Center, San Antonio, Texas, United States
Other microbiome trials you might be interested in